POST Online Media Lite Edition


DOR BioPharma Appoints Brian L. Hamilton as Chief Medical Officer

Staff writer |
Ewing, N.J., USA - March 13, 2009, Ewing, N.J., USA - DOR BioPharma, Inc. announced that it has appointed Brian L. Hamilton as Senior Vice President and Chief Medical Officer.

Article continues below

Dr. Hamilton earned his MD and PhD (Transplantation Immunology) at the University of Washington, Seattle, and trained in Pediatrics, Allergy/Immunology, and Oncology.

Dr. Hamilton began his training in bone marrow transplantation while in medical school, with further training at the Children's Hospital Medical Center, Boston, MA. His academic career, at the University of Washington and the University of Miami, focused on pediatric immunology and bone marrow transplantation. Dr. Hamilton's research focus was in the immunobiology of GVHD in an animal model. Dr. Hamilton also spent several years as Chief of Immunology at the Children's Hospital, Oakland, CA with a clinical appointment on the Pediatric Bone Marrow Transplant Service at the University of California - San Francisco.


What to read next

Sun BioPharma appoints David Kaysen as CEO
Array BioPharma appoints Victor Sandor as chief medical officer
PDL BioPharma CFO resigns